Design, synthesis and antiviral activity of α-L-arabinofuranosyl derivatives of 2-substituted-5,6-dichlorobenzimidazoles

Nucleosides and Nucleotides

Volumn 17, Issue 12, 1998, Pages 2389-2401

  Girardet, Jean Luc ^a   Drach, John C ^a   Chamberlain, Stanley D ^b   Koszalka, George W ^b   Townsend, Leroy B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOHEPTYLAMINO 5,6 DICHLORO 1 (ALPHA ARABINOFURANOSYL)BENZIMIDAZOLE; 2,5,6 TRICHLORO 1 (BETA RIBOFURANOSYL)BENZIMIDAZOLE; 5,6 DICHLORO 2 ISOPROPYLAMINO 1 (BETA RIBOFURANOSYL)BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; CIDOFOVIR; FOSCARNET; GANCICLOVIR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE RESPONSE; DRUG CYTOTOXICITY; HERPES VIRUS; NONHUMAN; POLYMERIZATION;

CYTOMEGALOVIRUS; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 0031757645     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808004326     Document Type: Article

References (28)

1. Alford, C. A.; Britt, W. J. Cytomegalovirus. In The Human Herpesviruses. Alford, C. A.; Britt, W. J., Ed.; Raven Press: New York, 1993, pp 227-255.
2. Wingard, J. R.; Piantadosi, S.; Burns, W. H.; Zahurak, M. L.; Santos, G. W.; Saral, R. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy. Rev. Infect. Dis. 1990, 12, S793-S804.
3. McKenzie, R.; Travis, W. D.; Dolan, S. A.; Pittaluga, S.; Feuertein, I. M.; Shelhamer, J.; Yarchoan, R.; Masur, H. The cause of death in patients with human immunodeficiency virus infection: a clinical and pathological study with emphasis on the role of pulmonary diseases. Medicine 1991, 70, 326.
4. Britt, W. J.; Pass, R. F.; Stagno, S.; Alford, C. A. Pediatric cytomegalovirus infection. Transplant. Proc. 1991, 23, 115-117.
5. Crumpacker, C. S. Ganciclovir. N. Engl. J. Med. 1996, 335, 721-729.
6. Chrisp, P.; Clissold, S. P. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991, 41, 104-129.
7. Hitchcock, M. J.; Jaffe, H. S.; Martin, J. C.; Stagg, R. J. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem. Chemother. 1996, 7, 115-127.
8. Field, A. K.; Biron, K. K. "The end of innocence" revisited: resistance to antiviral drugs. Clin. Microbiol. Rev. 1994, 7, 1-13.
9. Townsend, L. B.; Devivar, R. V.; Turk, S. T.; Nassiri, M. R.; Drach, J. C. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1995, 38, 4098-4105.
10. Zou, R.; Drach, J. C.; Townsend, L. B. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-β-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections. J. Med. Chem. 1997, 40, 811-818.
11. Zou, R.; Drach, J. C.; Townsend, L. B. Design, synthesis and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-β-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections. J. Med. Chem. 1997, 40, 802-810.
12. Zou, R.; Ayres, K. R.; Drach, J. C.; Townsend, L. B. Synthesis and antiviral activity of certain disubstituted benzimidazole ribonucleotides. J. Med. Chem. 1996, 39, 3477-3482.
13. Devivar, R. V.; Kawashima, E.; Revankar, G. R.; Breitenbach, J. M.; Kreske, E. D.; Drach, J. C.; Townsend, L. B. Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1994, 37, 2942-2948.
14. Gudmundsson, K. S.; Drach, J. C.; Wotring, L. L.; Townsend, L. B. Synthesis and antiviral activity of certain 5′-modified analogs of 2,5,6-trichloro-1-(β-D-ribofuranosyl)benzimidazole. J. Med. Chem. 1997, 40, 785-793.
15. Koszalka, G. W.; Chamberlain, S. D.; Daluge, S. M.; Boyd, F. L.; Tidwell, J. H.; Martin, M. T.; Harvey, R. J.; Frick, L. W.; Perkins, D. G.; Wang, L. H.; Drach, J. C.; Townsend, L. B.; Biron, K. K. Benzimidazoles for the treatment of HCMV infection. XII International Roundtable: Nucleosides, Nucleotides and their Biological Application, La Jolla, CA, September 15-19, 1996, OP 41, 56.
16. Chamberlain, S. D.; Chan, J. H.; Tidwell, J. H.; Peckham, G. E.; Harvey, R. J.; Dornsife, R. E.; Frick, L. W.; Townsend, L. B.; Drach, J. C.; Koszalka, G. W. Synthesis and evaluation of a series of carbohydrate modified derivatives of the anti-HCMV agent, 5,6-dichloro-2-isopropylamino-1-(β-L-ribofuranosyl)benzimidazole (1263W94). 213th ACS National Meeting, San Francisco, CA, April 13-17, 1997, Carbohydrates, 022.
17. Underwood, M. R.; Harvey, R. J.; Stanat, S. C.; Hemphill, M. L.; Miller, T.; Drach, J. C.; Townsend, L. B.; Biron, K. K. Inhibition of HCMV DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 1998, 72, 717-725.
18. Drach, J. C.; Bush, P. M.; Ptak, R. G.; Devivar, R. V.; Townsend, L. B.; Davis, M. G.; Underwood, M. R.; Biron, K. K. Halogenated benzimidazole 5′-deoxyribonucleosides are potent and selective inhibitors of human cytomegalovirus replication. 35th Interscience Conf. Antimicrob. Agents Chemother., San Francisco, CA, 1995,
19. Guthrie, R. D.; Smith, S. C. An improved preparation of 1,2,3,5-tetra-O-acetyl-β-D-ribofuranose. Chem. Ind. 1968, 547-548.
20. Kam, B. L.; Barascut, J.-L.; Imbach, J.-L. A general method of synthesis and isolation, and an N.M.R.-spectroscopic study, of tetra-O-acetyl-D-aldopentofuranoses. Carbohydr. Res. 1979, 69, 135-142.
21. Hinkley, J. M.; Porcari, A. R.; Walker, J. A. I.; Swayze, E. E.; Townsend, L. B. An improved large-scale preparation of benzimidazole-2-sulfonic acids and 2-chlorobenzimidazoles. Synth. Commun. 1998, 28, 1703-1712.
22. Harrison, D.; Ralph, J. T. Nucleophilic substitution reaction of 2-chlorobenzimidazoles. Part 1. Formation of benzimidazolin-2-ones and 2-alkoxybenzimidazoles. J. Chem. Soc. 1965, 236-239.
23. Migawa, M. T.; Girardet, J.-L.; Walker II, J. A.; Koszalka, G. W.; Chamberlain, S. D.; Drach, J. C.; Townsend, L. B. Design, synthesis, and antiviral activity of α-nucleosides: D-and L-isomers of lyxofuranosyl and 5-deoxy-lyxofuranosyl benzimidazoles. J. Med. Chem. 1998, 41, 1242-1251.
24. Mizutani, K.; Kasai, R.; Nakamura, M.; Tanaka, O.; Matsuura, H. N.M.R. spectral study of α- and β-L-arabinofuranosides. Carbohydr. Res. 1989, 185, 27-38.
25. Turk, S. R.; Shipman, C. J.; Nassiri, M. R.; Genzingler, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitor of human cytomegalovirus. Antimicrob. Agents Chemother. 1981, 31, 544-550.
26. Prichard, M. N.; Turk, S. R.; Coleman, L. A.; Engelhardt, S. L.; Shipman, C. J.; Drach, J. C. A microtiter virus reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus. J. Virol. Methods 1990, 28, 101-106.
27. Prichard, M. N.; Shipman, C. J. A three dimensional model to analyse drug-drug interactions. Antiviral Res. 1990, 14, 181-206.
28. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C. J. Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antiviral Res. 1991, 55, 1060-1065.